Cagrilintide
An amylin analogue developed for receptor and metabolic-signalling research.
What is it?
Cagrilintide is a modified analogue of amylin, a peptide hormone. It belongs to a different molecular family from GLP-1 receptor agonists.
What does the research explore?
The original development study describes peptide design, receptor-binding experiments and structural characterisation of a long-acting amylin analogue.
How to interpret the evidence
Results from a defined research material do not establish the identity or properties of an independently supplied product.
Study findings apply to the material and experimental conditions used by the researchers. They do not show that a PepVision product produces the same effects, or establish a personal-use dose.
Available presentation
Cagrilintide · 5 mg. Check the product page for current pricing and documentation.
Preparation and study protocols
Use a validated laboratory procedure for the exact material, solvent and study. Contact us for the available specification and lot documents. This overview does not prescribe a preparation method, administration route or dosing schedule.
Sources
For research purposes only. Not for human or animal consumption.